1   Of patients with a distal tubulovillous or villous adenoma, 12.1% had advanced proximal neoplasia.

2 4-21.45; P < .001), as was the prevalence of villous adenomas (5.5% vs 1.3% in unexposed; mOR = 6.28;

3 s (i.e., adenomas at least 1 cm in diameter, villous adenomas, adenomas with high-grade dysplasia, or

4 ssion; specimens of inflammatory bowel and a villous adenoma also had no detectable CRD-BP.

5 d as an adenoma 10 mm or more in diameter, a villous adenoma, an adenoma with high-grade dysplasia, o

6 denoma that was 10 mm or more in diameter, a villous adenoma, an adenoma with high-grade dysplasia, o

7 denoma that was 10 mm or more in diameter, a villous adenoma, an adenoma with high-grade dysplasia, o

8 ents had very high-risk lesions, i.e., large villous adenomas and multiple large polyps during severa

9  and expression of T-antigen in precancerous villous adenomas and regions of invasive adenocarcinoma.

10 a > or =10 mm, 6.05 (95% CI: 2.48-14.71) for villous adenoma, and 6.87 (95% CI: 2.61-18.07) for adeno

11 ination had neoplasms (one carcinoma and one villous adenoma) at colonoscopy.

12 enoma with a diameter of at least 10 mm or a villous adenoma in 7.9 percent, an adenoma with high-gra

13                                              Villous adenomas (n = 545; 3.6 %), dysplasia (n = 49; 0.

14 us adenoma with high grade dysplasia, n = 3; villous adenoma, n = 3), and 20 cases with newly diagnos

15 n malignant renal cell carcinoma and colonic villous adenoma, regulates TET2 protein expression.

16 es, having a distal tubulovillous adenoma or villous adenoma was the strongest predictor of advanced

17  adenomas, seven tubulovillous adenomas, one villous adenoma with marked dysplasia, and two cancers.

18          Heterogeneous staining was found in villous adenomas with focal intramucosal adenocarcinoma